Gene · 7994
Papers1,720
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,720
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| KAT6A inhibitor-loaded and anti-PD-L1-coated manganese metal-organic framework nanoplatform for enhanced colorectal cancer immunotherapy via cGAS-STING activation. | Int J Pharm X | 2026 | 42756777 | PubTator, text mining | PubMed |
| Tandem Double Inversion Resolves the Structural Paradox Underlying Recurrent KAT6A::NCOA2 Fusion in Acute Myeloid Leukemia. | Genes Chromosomes Cancer | 2026 | 42704008 | PubTator, text mining | PubMed |
| KAT6A-inhibitor co-crystal structures: tackling a challenging crystallization target via two alternative approaches. | Acta Crystallogr D Struct Biol | 2026 | 42657771 | PubTator, text mining | PubMed |
| Targeted Degradation of KAT6A: Expanding the Therapeutic Frontier of Epigenetic Drug Discovery. | ACS Med Chem Lett | 2026 | 42621538 | PubTator, text mining | PubMed |
| An Explicit Interaction-Prompted Diffusion Framework for High-Fidelity 3D Molecular Generation. | J Am Chem Soc | 2026 | 42619129 | PubTator, text mining | PubMed |
| Integrated population-based evidence, network toxicology, single-cell profiling, and in vitro studies elucidate mechanisms connecting PAHs to stroke. | Ecotoxicol Environ Saf | 2026 | 42594829 | PubTator, text mining | PubMed |
| Beyond acetylation: Evaluating the emerging biology of lysine acylation. | Cell Chem Biol | 2026 | 42586062 | PubTator, text mining | PubMed |
| OverlappING and DivergING roles of ING4 and ING5 in cancer, differentiation and development. | Front Cell Dev Biol | 2026 | 42577687 | PubTator, text mining | PubMed |
| Expanding the Hematologic Phenotype of Arboleda-Tham Syndrome: A Novel KAT6A Variant Associated With Bone Marrow Failure Requiring Hematopoietic Stem Cell Transplantation. | Pediatr Blood Cancer | 2026 | 42479970 | PubTator, text mining | PubMed |
| Circulating epigenetic and epitranscriptomic biomarkers identify EGFR status, predict TKI response and reveal therapeutic vulnerabilities in NSCLC. | Sci Rep | 2026 | 42477403 | PubTator, text mining | PubMed |
| Histone acetyltransferases as integrative epigenetic regulators of plant abiotic stress responses. | Plant Cell Rep | 2026 | 42463562 | PubTator, text mining | PubMed |
| Developmental and Structural Alterations at the Ductus-Aortic Isthmus Interface in Infantile Coarctation of the Aorta: A Biological Basis for Persistent Vascular Disease Beyond Anatomical Repair. | J Clin Med | 2026 | 42452674 | PubTator, text mining | PubMed |
| DEK recruits KAT6A regulate H3K27ac/c-myc axis to drive enhanced glycolysis and immune escape in gastric cancer. | Free Radic Biol Med | 2026 | 42419650 | PubTator, text mining | PubMed |
| Chromatin chronicles: Unlocking the therapeutic potential of histone modifiers in hepatocellular carcinoma. | Med Oncol | 2026 | 42360649 | PubTator, text mining | PubMed |
| TRERNA1-mediated acetylation represses ferroptosis of non-small cell lung cancer cells via the KAT6A/H3K23ac/TRIM24-PIK3CA pathway. | Hum Cell | 2026 | 42340519 | PubTator, text mining | PubMed |
| The roles of the acetyltransferase domains of the chromatin regulators KAT6A and KAT6B in vivo. | Development | 2026 | 42227022 | PubTator, text mining | PubMed |
| KATs in the MYST: A New Therapeutic Vulnerability for SETBP1-Mutated Myeloid Malignancies. | Blood Cancer Discov | 2026 | 42223213 | PubTator, text mining | PubMed |
| Histone H4K5 deacetylation by enhanced HDAC1 expression drives endothelial inflammation in diabetes through repression of the KLF2-eNOS axis. | Hum Cell | 2026 | 42207449 | PubTator, text mining | PubMed |
| KAT6A Promotes Lung Cancer Proliferation and Invasion via Keap1-Nrf2 Signaling. | Adv Biol (Weinh) | 2026 | 42076893 | PubTator, text mining | PubMed |
| Expanding the Clinical Spectrum of Arboleda-Tham Syndrome: Neuroimaging Findings and Hematologic Manifestations. | Neurol Genet | 2026 | 42040242 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7994/papers